ABSCI CORP Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
ABSCI CORP (ABSI) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $1.15 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2025-11-12
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $2.51M, a 80.22% increase year-over-year.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $2.05M, a 40.62% increase year-over-year.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$3.41M.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $760.00K.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was -$295.00K.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was -$1.21M.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$1.71M, a 393.80% decline from fiscal 2021.
- ABSCI CORP increase (decrease) in other accounts payable and accrued liabilities for fiscal 2021 was $581.00K, a 44.82% decline from fiscal 2020.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.56M derived: sum of 2 quarters · filed 2025-11-12 | $1.15M 10-Q · filed 2025-11-12 | $1.91M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.36M 10-Q · filed 2025-08-12 | -$601.00K derived: sum of 3 quarters · filed 2025-08-12 | $794.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | -$3.41M 10-Q · filed 2025-05-13 | -$2.65M derived: sum of 2 quarters · filed 2025-05-13 | -$1.25M derived: sum of 3 quarters · filed 2025-11-12 | $203.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.15M derived: sum of 2 quarters · filed 2025-11-12 | $3.61M derived: sum of 3 quarters · filed 2025-11-12 | -$295.00K 10-K · filed 2025-03-18 |
| 2024-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.85M derived: sum of 2 quarters · filed 2025-11-12 | -$1.05M 10-Q · filed 2025-11-12 | -$1.43M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.45M 10-Q · filed 2025-08-12 | -$2.82M derived: sum of 3 quarters · filed 2025-08-12 | $140.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$3.90M 10-Q · filed 2025-05-13 | -$4.28M derived: sum of 2 quarters · filed 2025-05-13 | -$1.31M derived: sum of 3 quarters · filed 2025-05-13 | -$2.69M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.59M derived: sum of 2 quarters · filed 2025-03-18 | $1.21M derived: sum of 3 quarters · filed 2025-03-18 | -$1.21M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.59M derived: sum of 2 quarters · filed 2024-11-12 | -$839.00K 10-Q · filed 2024-11-12 | -$1.34M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$3.80M 10-Q · filed 2024-08-14 | -$4.30M derived: sum of 3 quarters · filed 2024-08-14 | -$378.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$2.43M 10-Q · filed 2024-05-14 | -$2.93M derived: sum of 2 quarters · filed 2024-05-14 | $998.00K derived: sum of 3 quarters · filed 2024-05-14 | $397.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $3.42M derived: sum of 2 quarters · filed 2024-03-21 | $2.82M derived: sum of 3 quarters · filed 2024-03-21 | -$1.71M 10-K · filed 2024-03-21 |
| 2022-09-30 | $3.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.32M derived: sum of 2 quarters · filed 2023-11-14 | -$1.21M 10-Q · filed 2023-11-14 | $941.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$601.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$5.13M 10-Q · filed 2023-08-14 | -$2.98M derived: sum of 3 quarters · filed 2023-08-14 | -$4.15M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$4.53M 10-Q · filed 2023-05-15 | -$2.38M derived: sum of 2 quarters · filed 2023-05-15 | -$3.55M derived: sum of 3 quarters · filed 2023-05-15 | -$4.39M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $985.00K derived: sum of 2 quarters · filed 2023-03-30 | $137.00K derived: sum of 3 quarters · filed 2023-03-30 | $581.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.01M derived: sum of 2 quarters · filed 2022-11-09 | -$1.57M 10-Q · filed 2022-11-09 | -$558.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$848.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$404.00K 10-Q · filed 2022-08-11 | $605.00K derived: sum of 3 quarters · filed 2022-08-11 | $699.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $444.00K 10-Q · filed 2022-05-11 | $1.45M derived: sum of 2 quarters · filed 2022-05-11 | $1.55M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.10M derived: sum of 2 quarters · filed 2022-03-22 | $1.05M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $44.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$50.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |